InspireMD Inc (NSPR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $28.07M
Last updated: Nov 17, 2026 at 4:38 PM ET
InspireMD Inc (NSPR) Statistics
InspireMD (NSPR) has a market cap of $28.07M and an enterprise value of $10.54M. Its share count is up 16.54% from a year earlier. It holds $17.54M more cash than debt, 62.47% of its market cap.
Total Valuation
Enterprise value is 62.47% below the market cap, as cash exceeds debt.
| Market Cap | $28.07M |
|---|---|
| Enterprise Value | $10.54M |
| Latest price (Nov 17, 2026) | $0.65 |
Key Dates
The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.3x and 2.6x. Its year-end P/S ranged from 0.5x to 15.5x from 2019 to 2025.
| P/S Ratio | 5.3x |
|---|---|
| Forward P/S | 2.9x |
| P/B Ratio | 2.6x |
Price Statistics
The stock is down 69.19% over 52 weeks and trades 4.84% above its 50-day average.
| Beta (1Y) | 1.45 |
|---|---|
| 52-Week Change | -69.19% |
| 1-Month Change | +47.73% |
| 3-Month Change | -28.56% |
| 6-Month Change | -35.00% |
| 5-Year Change | -88.64% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -69.19% |
| Total Return (3Y CAGR) | -39.35% |
| Total Return (5Y CAGR) | -28.81% |
| Max Drawdown (1Y) | -79.60% |
| Max Drawdown (3Y) | -88.15% |
| Sharpe Ratio (1Y) | -1.46 |
| Correlation with SPY (1Y) | 0.26 |
| 50-Day Average | $0.62 |
| 200-Day Average | $1.01 |
| 52-Week Range | $0.43 to $2.17 |
| RSI (14 Days) | 52.1 |
| Average Volume (20 Days) | 498.82K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.99x current liabilities, and total debt is 0.08x shareholder equity.
| Current Ratio | 2.99x |
|---|---|
| Quick Ratio | 2.64x |
| Debt / Equity | 0.08x |
Returns and Efficiency
Return on invested capital is -163.84% over the last 12 months, against a 5-year average of -74.35%.
| Return on Assets (ROA) | -105.93% |
|---|---|
| Return on Invested Capital (ROIC) | -163.84% |
| ROE (5Y Average) | -75.66% |
| ROA (5Y Average) | -58.61% |
| ROIC (5Y Average) | -74.35% |
| Inventory Turnover | 3.24x |
| Receivables Turnover | 4.45x |
| Cash Conversion Cycle | -8 days |
Scores
NSPR has an Altman Z-Score of -14.21, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -14.21 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Balance Sheet
| Cash and Equivalents | $19.25M |
|---|---|
| Total Debt | $1.71M |
| Net Cash | $17.54M |
| Net Cash Per Share | $0.20 |
Balance sheet as of Sep 30, 2026.
Growth
Revenue grew 20.19% a year over 3 years.
| Revenue Growth (3Y CAGR) | +20.19% |
|---|---|
| Revenue Growth (5Y CAGR) | +29.29% |
| Book Value Per Share Growth (2Y CAGR) | -32.06% |
| Tangible Book Per Share Growth (2Y CAGR) | -32.06% |
Dividends and Yields
NSPR does not pay a dividend. Its free cash flow yield is -79.75%.
| FCF Yield | -79.75% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-15 reverse split on Apr 27, 2021.
| Last Split Date | Apr 27, 2021 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 11 similar companies, NSPR has the 4th highest P/S.
P/S RatioPeer median 1.3x
ROICPeer median -111.14%
| P/S Ratio | 5.3x vs 1.3x median |
|---|---|
| ROIC | -163.84% vs -111.14% median |
Analyst Forecast
Consensus estimates put revenue growth at 49.74% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +49.74% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NSPR
What is NSPR's market cap?
InspireMD has a market cap of $28.07M. Its enterprise value, which adds debt and subtracts cash, is $10.54M.
How many shares of NSPR are outstanding?
InspireMD has 85.62M shares outstanding. The count is up 16.54% from a year earlier.
Does NSPR pay a dividend?
No. InspireMD does not pay a dividend.
How much debt does NSPR have?
InspireMD has $1.71M of total debt and $19.25M of cash and equivalents, a net cash position of $17.54M.
NSPR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors